Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4 is a type I transmembrane glycoprotein expressed on T helper cells, monocytes, macrophages, and NK cells. It functions as a co-receptor for the T cell receptor (TCR) and MHC class II interaction, facilitating T cell activation and immune responses. It is also the primary receptor for HIV entry into cells and a target for immunotherapies in autoimmunity and transplantation.
CD4 acts as a co-receptor to enhance T cell receptor signaling by binding to MHC class II molecules and recruiting Lck kinase to phosphorylate CD3 ITAMs. It also serves as a primary receptor for HIV entry into cells.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cluster of Differentiation 4 (CD4).